496 related articles for article (PubMed ID: 23862076)
1. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.
Pilar-Cuéllar F; Vidal R; Díaz A; Castro E; dos Anjos S; Pascual-Brazo J; Linge R; Vargas V; Blanco H; Martínez-Villayandre B; Pazos Á; Valdizán EM
Neural Plast; 2013; 2013():537265. PubMed ID: 23862076
[TBL] [Abstract][Full Text] [Related]
2. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
Masi G; Brovedani P
CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity.
Pilar-Cúellar F; Vidal R; Díaz A; Castro E; dos Anjos S; Vargas V; Romero B; Valdizán EM
Curr Pharm Des; 2014; 20(23):3776-94. PubMed ID: 24180397
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats.
Hu Y; Liao HB; Dai-Hong G; Liu P; Wang YY; Rahman K
Neurochem Int; 2010 Feb; 56(3):461-5. PubMed ID: 20018220
[TBL] [Abstract][Full Text] [Related]
5. Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.
Xu W; Yao X; Zhao F; Zhao H; Cheng Z; Yang W; Cui R; Xu S; Li B
Neural Plast; 2020; 2020():8861903. PubMed ID: 33293948
[TBL] [Abstract][Full Text] [Related]
6. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy.
Paizanis E; Hamon M; Lanfumey L
Neural Plast; 2007; 2007():73754. PubMed ID: 17641737
[TBL] [Abstract][Full Text] [Related]
8. Alterations of neuroplasticity in depression: the hippocampus and beyond.
Fuchs E; Czéh B; Kole MH; Michaelis T; Lucassen PJ
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S481-90. PubMed ID: 15550346
[TBL] [Abstract][Full Text] [Related]
9. Does neurotropin-3 have a therapeutic implication in major depression?
Pae CU; Marks DM; Han C; Patkar AA; Steffens D
Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
[TBL] [Abstract][Full Text] [Related]
10. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.
Castrén E; Rantamäki T
Dev Neurobiol; 2010 Apr; 70(5):289-97. PubMed ID: 20186711
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment.
Warner-Schmidt JL; Duman RS
Hippocampus; 2006; 16(3):239-49. PubMed ID: 16425236
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants and neuroplasticity.
D'Sa C; Duman RS
Bipolar Disord; 2002 Jun; 4(3):183-94. PubMed ID: 12180273
[TBL] [Abstract][Full Text] [Related]
13. Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
Hirshler Y; Doron R
Eur Neuropsychopharmacol; 2017 Oct; 27(10):945-958. PubMed ID: 28807619
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant drug action--From rapid changes on network function to network rewiring.
Rantamäki T; Yalcin I
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():285-92. PubMed ID: 26066070
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptides in depression: role of VGF.
Thakker-Varia S; Alder J
Behav Brain Res; 2009 Feb; 197(2):262-78. PubMed ID: 18983874
[TBL] [Abstract][Full Text] [Related]
16. Neural Plasticity Is Involved in Physiological Sleep, Depressive Sleep Disturbances, and Antidepressant Treatments.
Zhang MQ; Li R; Wang YQ; Huang ZL
Neural Plast; 2017; 2017():5870735. PubMed ID: 29181202
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone.
Olescowicz G; Neis VB; Fraga DB; Rosa PB; Azevedo DP; Melleu FF; Brocardo PS; Gil-Mohapel J; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():395-407. PubMed ID: 28842257
[TBL] [Abstract][Full Text] [Related]
18. Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients.
Lucassen PJ; Stumpel MW; Wang Q; Aronica E
Neuropharmacology; 2010 May; 58(6):940-9. PubMed ID: 20138063
[TBL] [Abstract][Full Text] [Related]
19. S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice.
Pilar-Cuellar F; Castro E; Bretin S; Mocaer E; Pazos Á; Díaz Á
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():205-213. PubMed ID: 30980840
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms in the long-term action of antidepressants.
Racagni G; Popoli M
Dialogues Clin Neurosci; 2008; 10(4):385-400. PubMed ID: 19170396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
